Search
for
Sort by
Research 121–150 of 1000+
- Characteristic microstructure of curved human hair
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Hair loss in the elderly
- Drugs affecting blood coagulation, fibrinolysis, and hemostasis
- Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe?
- In-Vitro Release of Zinc Pyrithione from A Shampoo Base and the Effects of Various Additives on its Release Rate
- Male Senescence Phenotypes Include Hair Loss and Hair Gain
- Precocious Puberty: A Case Report
- Designing, Optimising, and Assessing a Novel Emulgel Containing Minoxidil for Controlled Drug Release, Incorporating Marine-based Polymers
- Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey
- Alopecia in three macaque species housed in a laboratory environment
- Impact of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance database
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Traction Alopecia Due to Traditional Hair Styles
- Abstract 850: Androgenic alopecia and risks of overall and aggressive prostate cancer: An updated meta-analysis
- Scalp photodamage in balding men: An observational study combining a novel clinical scoring method with estimation of individual sun exposure history and risk factors
- Utilization of trichological services by elderly persons — case study of Hairmitage Clinic
- Effects of Hair Loss on Depression in Generation MZ
- Therapy for Androgenetic Alopecia
- 흰목이버섯(Tremella fuciformis Berk)의 스트레스 마우스에 대한 모낭과 모발 성장 정도
- Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study
- State of the Science Burn Research: Burns in the Elderly
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Timing of puberty in relation to semen characteristics, testicular volume, and reproductive hormones: a cohort study
- Prevalence and predictors of persistent post-COVID-19 symptoms
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies